S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

Carcinogenesis
José L Marín-RubioMaría Villa-Morales

Abstract

T-cell lymphoblastic lymphoma is a haematological disease with an urgent need for reliable prognostic biomarkers that allow therapeutic stratification and dose adjustment. The scarcity of human samples is responsible for the delayed progress in the study and the clinical management of this disease, especially compared with T-cell acute lymphoblastic leukaemia, its leukemic counterpart. In the present work, we have determined by immunohistochemistry that S194-P-FADD protein is significantly reduced in a cohort of 22 samples from human T-cell lymphoblastic lymphoma. Notably, the extent of such reduction varies significantly among samples and has revealed determinant for the outcome of the tumour. We demonstrate that Fas-associated protein with death domain (FADD) phosphorylation status affects protein stability, subcellular localization and non-apoptotic functions, specifically cell proliferation. Phosphorylated FADD would be more stable and preferentially localized to the cell nucleus; there, it would favour cell proliferation. We show that patients with higher levels of S194-P-FADD exhibit more proliferative tumours and that they present worse clinical characteristics and a significant enrichment to an oncogenic signature. This...Continue Reading

References

Apr 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Robert A ScreatonSteven M Frisch
Jun 20, 2003·Cell Death and Differentiation·M Gómez-Angelats, J A Cidlowski
Nov 17, 2004·IUBMB Life·Jing ZhangZichun Hua
Feb 19, 2005·Medical Immunology·Léa TourneurGilles Chiocchia
Aug 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Guoan ChenAlnawaz Rehemtulla
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Feb 2, 2006·British Journal of Cancer·S MatsuyoshiN Konishi
Nov 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Johan H GibcusEd Schuuring
Apr 19, 2008·Nature Reviews. Immunology·Iannis AifantisSilvia Buonamici
Feb 24, 2009·Critical Reviews in Oncology/hematology·Laurence de LevalPhilippe Gaulard
Dec 8, 2009·British Journal of Haematology·Birgit Burkhardt
Jun 26, 2010·Trends in Immunology·Léa Tourneur, Gilles Chiocchia
Sep 22, 2010·Journal of Biomolecular Screening·Amjad P KhanAlnawaz Rehemtulla
Dec 1, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephen RosenbergJianke Zhang
Jan 14, 2011·Journal of Gastroenterology and Hepatology·Jorn Markus SchattenbergPeter Robert Galle
Jan 3, 2012·International Journal of Radiation Oncology, Biology, Physics·Michiel L SchrijversE Schuuring
Jan 14, 2012·Expert Opinion on Therapeutic Targets·María Villa-Morales, José Fernández-Piqueras
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Celine CallensElizabeth Macintyre
Oct 2, 2012·The Journal of Clinical Investigation·Pieter Van Vlierberghe, Adolfo Ferrando
Jul 13, 2013·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Mihir R PatelD Neil Hayes
Mar 8, 2014·Cell Death & Disease·M Villa-MoralesJ Fernández-Piqueras
Apr 18, 2014·Blood·Kheira BeldjordUNKNOWN Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
Aug 28, 2014·British Journal of Haematology·Bettina R BonnBirgit Burkhardt
Apr 8, 2015·Cell Death and Differentiation·M E PeterP Ceppi
Apr 9, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D HoelzerUNKNOWN ESMO Guidelines Committee
Jul 28, 2016·Nature Reviews. Cancer·Laura Belver, Adolfo Ferrando
Aug 25, 2016·Oncotarget·José L Marín-RubioMaría Villa-Morales
Apr 22, 2017·Critical Reviews in Oncology/hematology·Sergio CortelazzoMaurilio Ponzoni
Apr 30, 2017·Oncology Letters·Rong ZhangZi-Chun Hua

❮ Previous
Next ❯

Citations

Sep 24, 2020·International Journal of Molecular Sciences·Kishu RanjanChandramani Pathak
Oct 2, 2019·Cancers·José L Marín-RubioMaría Villa-Morales

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.